We advise leading pharmaceutical companies on the evaluation and divestment of drug manufacturing and R&D sites. We are also experts in licensing products, compounds, IP and technologies.
Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:
Find out more View All
We are delighted to announce that Results Healthcare acted as exclusive financial advisor to GHO Capital, on its acquisition, alongside management, of Sterling Pharma Solutions - a specialist in complex and difficult to manufacture active pharmaceutical ingredients (APIs).